Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
NASDAQ 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
NIKKEI 14,951.77 467.79 3.23%
TOPIX 1,222.00 33.66 2.83%
HANG SENG 22,757.81 88.13 0.39%

Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference



Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference

PR Newswire

HAYWARD, Calif., Nov. 20, 2012

HAYWARD, Calif., Nov. 20, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
(Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious
diseases associated with inflammation and autoimmune disorders, today
announced that Paul F. Truex, Anthera's President and Chief Executive Officer,
will present at the Piper Jaffray Health Care Conference in New York, NY on
Tuesday, November 27, 2012, at approximately 3:30 pm Eastern Time.

Piper Jaffray Health Care Conference Presentation
Date/Time: Tuesday, November 27, at 3:30 pm Eastern Time
Location: The New York Palace

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing
and commercializing products to treat serious diseases associated with
inflammation and autoimmune diseases.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or
510.856.5586.

SOURCE Anthera Pharmaceuticals, Inc.

Website: http://www.anthera.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement